Who founded Neobe Therapeutics?

Neobe Therapeutics was founded by Pedro Correa de Sampaio, Annelise Soulier.

Who are Neobe Therapeutics's investors?

Neobe Therapeutics's investors include 2048 Ventures, Deep Science Ventures.

How much funding has Neobe Therapeutics raised?

Neobe Therapeutics has disclosed $2.3M raised across 1 round.

Neobe Therapeutics

5 known investors

Find your way into Neobe Therapeutics

141 people in our graph share verified history with the Neobe Therapeutics team — schools, employers, funds. One of them is your warm intro.

Richard Leeunlockedknows Annelise Soulier · together at University of Nottingham (overlapped)

×4knows the team · via University of Nottingham

×4knows the team · via The University of Edinburgh

×2knows the team · via Deep Science Ventures

knows the team · via University of Birmingham

NeoBe Therapeutics develops engineered live biotherapeutics for oncology, combining synthetic biology and immunology to create next-generation cell therapies. The company serves cancer patients through collaborations with leading academic institutions and investors.

Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Pedro Correa de SampaioCo-founder and CEO

Annelise Soulier inCo-founder and CSOShe brings background in microbiology, molecular biology, and immuno-oncology, with hands-on experience in vaccine development and application of multidisciplinary approaches to technology development.

Investors · 5

2048 Ventures✓ verifiedNew York · $500K – $3M

Deep Science VenturesLondon

Also in the syndicate · 3

Cancer Research HorizonsDiscovery Park VenturesPioneer Grouplead

Funding

SEC filings, press & company announcements

$2.3M disclosed across 1 round · 2024

$2.3MraisedFeb 2024 · 2 sources
Pioneer Group (lead), 2048 Ventures, Cancer Research Horizons, Deep Science Ventures, Discovery Park Ventures
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Pioneer Group Leads $2.34m Investment In Neobe Therapeutics' Cancer Therapy Innovation - Pioneer Groupthepioneergroup.com · Feb 2024

Neobe announces $2M fundraise — Neobe Therapeuticsneobetherapeutics.com · Feb 2024

Neobe Therapeutics raises over $2m for synthetic biology enabled tumour microenvironment remodelling - PharmiWeb.compharmiweb.com · Feb 2024

Neobe Therapeutics Raises £520K to Take Down Walls to Immunotherapy Success in Cancer Partient — Neobe Therapeuticsneobetherapeutics.com · Nov 2022

Frequently asked questions

What does Neobe Therapeutics do?: NeoBe Therapeutics develops engineered live biotherapeutics for oncology, combining synthetic biology and immunology to create next-generation cell therapies. The company serves cancer patients through collaborations with leading academic institutions and investors.
Who founded Neobe Therapeutics?: Neobe Therapeutics was founded by Pedro Correa de Sampaio, Annelise Soulier.
Who are Neobe Therapeutics's investors?: Neobe Therapeutics's investors include 2048 Ventures, Deep Science Ventures.
How much funding has Neobe Therapeutics raised?: Neobe Therapeutics has disclosed $2.3M raised across 1 round.